Nichi-Iko to Suspend Supply of Olmesartan OD Tab. 20 mg as COVID-19 Cripples API Procurement

Nichi-Iko Pharmaceutical has notified medical institutions in Japan that it will temporarily halt shipments of its ARB Olmesartan OD Tablets 20 mg “Nichi-Iko” (originator: Daiichi Sankyo’s Olmetec), due to a delay in API procurement amid the COVID-19 crisis. It expects...read more